Budding yeast cells suffering a single unrepaired double-strand break (DSB) trigger the Mec1 (ATR)-dependent DNA damage response that causes them to arrest before anaphase for 12-15 h. Here we find that hyperactivation of the cytoplasm-to-vacuole (CVT) autophagy pathway causes the permanent G2/M arrest of cells with a single DSB that is reflected in the nuclear exclusion of both Esp1 and Pds1. Transient relocalization of Pds1 is also seen in wild-type cells lacking vacuolar protease activity after induction of a DSB. Arrest persists even as the DNA damage-dependent phosphorylation of Rad53 diminishes. Permanent arrest can be overcome by blocking autophagy, by deleting the vacuolar protease Prb1, or by driving Esp1 into the nucleus with a SV40 nuclear localization signal. Autophagy in response to DNA damage can be induced in three different ways: by deleting the Golgi-associated retrograde protein complex (GARP), by adding rapamycin, or by overexpression of a dominant ATG13-8SA mutation.
Budding yeast cells suffering a single unrepaired double-strand break (DSB) trigger the Mec1 (ATR)-dependent DNA damage response that causes them to arrest before anaphase for 12-15 h. Here we find that hyperactivation of the cytoplasm-to-vacuole (CVT) autophagy pathway causes the permanent G2/M arrest of cells with a single DSB that is reflected in the nuclear exclusion of both Esp1 and Pds1. Transient relocalization of Pds1 is also seen in wild-type cells lacking vacuolar protease activity after induction of a DSB. Arrest persists even as the DNA damage-dependent phosphorylation of Rad53 diminishes. Permanent arrest can be overcome by blocking autophagy, by deleting the vacuolar protease Prb1, or by driving Esp1 into the nucleus with a SV40 nuclear localization signal. Autophagy in response to DNA damage can be induced in three different ways: by deleting the Golgi-associated retrograde protein complex (GARP), by adding rapamycin, or by overexpression of a dominant ATG13-8SA mutation.
adaptation | separase | securin | cell cycle arrest I n the presence of a single unrepairable DNA double-strand break (DSB), Saccharomyces cerevisiae arrest is due to Mec1 checkpoint kinase-dependent cell cycle arrest, but cells eventually escape from the arrest and reenter the cell cycle in a process termed adaptation (1) (2) (3) (4) (5) (6) . Arrest before adaptation typically lasts 12-15 h, a time equivalent to five to six normal cell cycles. Adaptation is accompanied by the loss of checkpoint-induced hyperphosphorylation of checkpoint kinases Rad53 and Chk1 and the loss of association with damaged DNA of the Mec1 (ATR) kinaseassociated Ddc2 (ATRIP), despite the persistence of DNA damage (7, 8) . Several proteins are required for adaptation, including those with known roles in DNA repair (Yku70, Yku80, Rdh54/ Tid1, Rad51, Srs2, Sae2, Fun30, and Sgs1), as well as proteins that are required to turn the checkpoint off (the PP2C phosphatases Ptc2 and Ptc3 and casein kinase II) and the Polo kinase Cdc5, which plays several roles in regulating mitosis (5, 6, (9) (10) (11) (12) (13) (14) .
When DSB repair is relatively rapid, as during HO endonuclease-induced mating-type (MAT) switching, there is no cell cycle arrest or Rad53 phosphorylation (7) , although Mec1 and Tel1 kinases rapidly phosphorylate histone H2A (15, 16) . However, when DSB repair is slower, e.g., during ectopic homologous recombination or long-distance single-strand annealing, the DNA damage checkpoint is fully activated and G2/M arrest is maintained for several hours until repair is effected and cells reenter the cell cycle in a process termed recovery (12, 17) . Recovery is an active process that requires the functions of the Srs2 helicase and also the casein kinase II and PP2C phosphatases to dephosphorylate checkpoint kinases (11) (12) (13) . None of the other adaptation mutants tested (yku70Δ, rdh54Δ, rad51Δ, sae2Δ, cdc5-ad, and fun30Δ) is deficient in recovery (12, 14) although a number of double mutants are recovery defective (3) . Analysis of checkpoint recovery in human cells has shown a requirement for the Plk1 polo kinase homologous to yeast Cdc5 and the mitotic phosphatase Cdc25 (17).
Although the DNA damage response leading to cell cycle arrest appears to be nuclear autonomous (18) , recent evidence has suggested that the checkpoint response involves alterations of cytoplasmic processes (19) (20) (21) (22) (23) (24) . Most notably, inhibition of several yeast histone deacetylases in cells suffering DNA damage results in the destruction of Sae2, a key DNA repair protein, by autophagy (25) . Very little is understood about how DNA damage triggers cytoplasmic responses and how autophagy might play a role in the regulation of cell cycle progression in the face of DNA damage. Here we report that mutations in the Golgi-associated retrograde protein (GARP) complex unexpectedly block checkpoint adaptation and recovery. We show that this defect is associated with an increase in autophagy-specifically in the selective cytoplasm-to-vacuole targeting (CVT) pathway. Increased autophagy after DNA damage causes the partial destruction of the chaperone/inhibitor securin (Pds1) that controls entry of separase (Esp1) into the nucleus to facilitate anaphase. The exclusion of Pds1 from the nucleus after DSB induction can be observed transiently in cells lacking vacuolar protease activity, but this state is maintained by increasing autophagy either by rapamycin inhibition of TOR or by overexpression of a dominant ATG13 mutation. The inhibition of permanent DNA damage-induced cell cycle arrest can be overcome by inhibiting autophagy, by inhibiting vacuolar proteolysis, or by driving Esp1 into the nucleus with a heterologous nuclear localization sequence (NLS).
Results
In a screen for new checkpoint recovery-defective mutations (Materials and Methods), we identified a transposon insertion in the VPS51 gene, a component of the GARP complex. Subsequently we found that complete deletions of VPS51 or other GARP genes (VPS52, VPS53, VPS54, and YPT6) prevent adaptation ( Fig. 1) , similar to the phenotype of a previously identified adaptation-defective mutation tid1Δ (hereafter referred to as rdh54Δ) (9) . Adaptation was assayed by inducing a HO endonuclease-mediated unrepairable DSB at the MAT locus and observing cells under the microscope for arrest at G2/M (dumbbellshaped cells) and subsequent budding (6) . GARP mutants all maintain arrest with the characteristic large-budded phenotype with a single DAPI-staining nucleus, usually at, or stretched across, the bud neck. This phenotype eliminates the possibility that mutants have completed mitosis but fail to bud in the next Author contributions: F.D., V.V.E., J.C.H., A.A.-E., S.Y., and J.E.H. designed research; F.D., V.V.E., J.C.H., A.A.-E., V.R., and S.Y. performed research; F.D., J.C.H., A.A.-E., and S.Y. contributed new reagents/analytic tools; F.D., V.V.E., J.C.H., A.A.-E., V.R., S.Y., and J.E.H. analyzed data; and F.D., V.V.E., J.C.H., S.Y., and J.E.H. wrote the paper.
The authors declare no conflict of interest. 1 cell cycle. We note that not all vacuolar protein-sorting (vps) mutants, all of which cause carboxypeptidase Y to be secreted rather than retained in the vacuole (26) , exhibit an adaptation defect; for example, vps25Δ and vps35Δ all display normal adaptation (Fig. 1 ).
To establish whether the defects in GARP mutants were specific to cell cycle arrest provoked by DNA damage, we asked if blocking cells with nocodazole before anaphase would also lead to a recovery defect. Log-phase cells grown in YEPD liquid medium were arrested for 12 h with 30 μg/mL nocodazole such that >95% were arrested as large dumbbells. These cells were then spread on YEPD without nocodazole to assess their ability to resume cell cycle progression and form colonies. vps51Δ cells exhibit a modest delay in cell cycle progression 8 h after release from nocodazole, but by 24 h 100% of both WT and vps51Δ cells progressed beyond the dumbbell stage (Fig. S1) . Hence, nocodazole arrest, which triggers the spindle checkpoint activation, does not cause the same defect, as does a single unrepaired DSB. It has been observed that GARP mutants, like other vps mutants, cause mislocalization of vacuolar proteases (26) ; hence the adaptation defect of GARP mutants could be due to the aberrant proteolytic degradation of a key mitotic activator. We therefore asked whether vps51Δ mutants are suppressed by deleting Pep4, which activates several vacuolar proteases (27) . We found a striking suppression of vps51Δ by pep4Δ ( Fig. 2A) . In contrast, there was no significant suppression of three adaptation-defective mutations involved in DNA metabolism or dephosphorylation of the checkpoint kinase cascade (rdh54Δ, srs2Δ, and ptc2Δ ptc3Δ).
Pep4 activates a number of vacuolar proteases. We established that deleting the gene encoding one of these, proteinase B (PRB1), showed the same suppression of the adaptation defects of vps51Δ as pep4Δ, again without affecting the other adaptation-defective mutations (Fig. 2B) . These results lead to the suggestion that cells with defects in retrograde vesicle trafficking fail to adapt because of the Prb1-dependent degradation of a necessary mitotic activator. Vps51 is required for adaptation to the DNA damage checkpoint. WT (JKM179) and vesicular transport mutants were tested in the checkpoint adaptation assay (Materials and Methods). Of these, WT cells adapt whereas vps51Δ, vps53Δ, and ypt6Δ were found to be adaptation defective. vps52Δ has a similar effect but was measured only at 24 h and is not shown for clarity. Retromer mutant (vps35Δ) and ESCRT II mutant (vps25Δ) were not adaptation defective. The rdh54Δ cells serve as positive control for the adaptation defect. Cells were pregrown in YEP-Lactate (YEPL) media overnight and then manipulated onto minimal complete media supplemented with 1% yeast extract and containing 2% galactose (CYG). The percentage of cells progressing beyond the "dumbbell" arrest stage ("percentage of adaptation") is shown. separase, Esp1, from releasing sister-chromatid cohesion (28) . There are several constraints on Esp1. First, it is inhibited by securin, Pds1, which is stabilized against APC/C-mediated degradation by Chk1-and Rad53-dependent phosphorylation (29) .
Second, Esp1 appears to be sequestered in the cytoplasm until the proper time in the cell cycle (30) . Nuclear import of Esp1 is at least in part mediated by Pds1 acting as a chaperone (31) although other chaperones may also play important roles (32) . To examine localization of Pds1 and Esp1, we integrated a GFP tag in the genomic copy of PDS1 or ESP1. Both PDS1-GFP and ESP1-GFP are functional, as the cells expressing these GFP fusion proteins in the absence of wild-type PDS1 or ESP1 did not show any detectable mitotic defects even at 37°C, whereas esp1Δ is lethal at all temperatures and pds1Δ is inviable at 37°C. The localization of Pds1-GFP and Esp1-GFP in rapidly growing cell cultures is consistent with previous reports (28, 30, 33) . Both tagged proteins accumulated in the nucleus in medium-to-large budded cells (Fig. S2) . When the cells were checkpoint arrested in G2/M phase by induction of a DSB and examined 6 h later, Pds1-GFP accumulated in the nucleus both in wild-type cells and in the adaptation-defective rdh54Δ strain (Fig. 3A) . However, in vps51Δ, Pds1-GFP is not concentrated in the nucleus and is apparently much less abundant, as measured by total fluorescence intensity of the cells (Fig. 3A) . This delocalization of Pds1-GFP in vps51Δ is specific to DNA damage-induced G2/M arrest; in large-budded growing cells and in nocodazole-arrested cells Pds1-GFP is mostly found in the nucleus (Figs. S2 and S3). Like Pds1-GFP, Esp1-GFP is strongly concentrated in the nucleus of DSB-arrested wild-type and rdh54Δ cells 6 h after DSB induction; however, in vps51Δ cells, nuclear accumulation of Esp1-GFP was not seen (Fig. 3A) . Remarkably, this defect in Esp1-GFP and Pds1-GFP localization is rescued by deleting PEP4 (Fig.3A) . These data support the idea that-in the GARP mutants-the DNA damage checkpoint response prevents nuclear accumulation of both Pds1 and Esp1, resulting in prolonged checkpoint-mediated arrest.
Pds1-GFP and Esp1-GFP were often found in endosome-like structures in the cytoplasm in vps51Δ pep4Δ cells (Fig. 3A) . Our attempts to visualize both Pds1-GFP and endosome/vacuole membranes were unsuccessful because vps51Δ has a fragmented vacuole and is defective in the endosomal marker FM4-64 uptake (34) . However, the altered localization and degradation of Pds1 are not only seen in these vps51Δ mutant cells, but also can be seen in pep4Δ cells after induction of an unrepaired DSB (Fig.  4) . To further examine whether Pds1 is targeted to the vacuole for degradation during DNA damage-induced G2 arrest, we carefully quantified Pds1-GFP localization in the cell, as described in Materials and Methods. In WT cells, 6 h after DSB induction, Pds1-GFP accumulates in the nucleus and is absent from the vacuole (less signal in the vacuole than in the cytoplasm, as seen in Fig. 4 ). In contrast, in pep4Δ cells, Pds1-GFP signal in the vacuolar area was much higher than in the cytoplasm. Vacuolar accumulation of Pds1-GFP in pep4Δ was further confirmed by staining the vacuole with FM4-64 (Fig. S4 ).
Degradation of Pds1 and Nuclear Localization Defects of Pds1 and
Esp1 in GARP Mutants Are Suppressed by PEP4 Deletion. Reduced nuclear Pds1 and Esp1 could be due to their mislocalization, degradation, or both. By Western blot analysis we found that Pds1-GFP levels were significantly lower in vps51Δ after DNA damage compared with WT and that the level of Pds1 in vps51Δ strains was restored by deletion of PEP4 (Fig. 3C ). Importantly, defective nuclear accumulation of Pds1-GFP in the vps51Δ strain was also restored by deletion of PEP4 (Fig. 3A) . The importance of Pds1 in nuclear localization of Esp1 has already been established (33) . These results are in agreement with the idea that the adaptation defect seen in vps51Δ is caused at least in part by the exclusion of Esp1 from the nucleus when Pds1 is partially degraded and apparently mislocalized in response to the DNA damage checkpoint in these mutant cells. Thus, stabilization of Pds1 is sufficient to drive Esp1 back into the nucleus. Consistent with the Western blotting data, Pds1-GFP is stabilized in pep4Δ and the GFP signal in the nucleus is much stronger, possibly explaining how pep4Δ could rescue the Pds1 localization defect in vps51Δ. These results lead to the surprising conclusion that cells with defects in retrograde vesicle trafficking fail to adapt because of the Pep4-and Prb1-dependent degradation of one or more necessary mitotic activators, including Pds1. Because Esp1 seems to be excluded from the nucleus after DNA damage in vps51Δ cells, we hypothesized that we could suppress the mislocalization of Esp1 by fusing it to the NLS of SV40 (30) . In our experiments the fusion protein gene was transcribed under the control of the normal chromosomal ESP1 promoter at its normal chromosomal location (Materials and Methods). Indeed, Esp1-NLS SV40 efficiently suppressed the adaptation defects of vps51Δ (Fig. 5) . Esp1-NLS SV40 does not affect the permanent arrest of rdh54Δ or ptc2Δ ptc3Δ, which presumably affects events entirely within the arrested nucleus. Esp1-NLS SV40 did partially suppress srs2Δ; in addition, wild-type cells adapt more completely when Esp1-NLS SV40 (superscripted as in other instances) is expressed. As we do not know the mechanism by which either srs2Δ or rdh54Δ blocks the process of adaptation, we cannot account for the difference. These data argue strongly that the disruption of normal vesicle traffic results in the retention or inactivation of Esp1 in a cytoplasmic compartment and this can be overcome when Esp1 is driven into the nucleus Inhibition of Adaptation in vps51Δ Requires Autophagy via the CVT Pathway. If Pds1 and/or other factors that are needed to facilitate Esp1 entry into the nucleus are degraded in vps51Δ strains, then there should be a pathway to direct these proteins to the vacuole or some other vesicular compartment harboring Prb1. Two major ways in which this might occur should involve either the targeted (CVT) or general autophagy pathways (35, 36) .
We first examined Atg1 and Atg5 mutations that affect both autophagy pathways (37) . In otherwise WT cells, a defect in autophagy did not affect adaptation, as seen by examining atg1Δ and atg5Δ mutations (Fig. 6 A and B) . However, when we constructed atg5Δ vps51Δ and atg1Δ vps51Δ double mutants, we found that these mutations suppressed the adaptation defect of vps51Δ ( Fig. 6 A and B) . Furthermore, deletion of atg5Δ did not suppress adaptation-defective mutants rdh54Δ, srs2Δ, and ptc2Δ ptc3Δ. We then examined atg17Δ and atg11Δ that are specifically required for the bulk and CVT pathways, respectively (37) . As seen in Fig. 6B , atg11Δ suppressed the permanent arrest of vps51Δ cells whereas atg17Δ did not. These results support the idea that the DNA damage-induced response involves the targeted degradation of mitotic regulators via the CVT pathway and that this phenotype is exacerbated in GARP mutants. We note that vps51Δ cells with knockouts in ESCRT2 (vps25Δ) or the retromer complex (vps35Δ) are still adaptation defective (Fig. S5) . Deletion of VPS64 is synthetically lethal with pds1Δ at normally permissive temperatures (31) , which could suggest that it plays an alternative role in transport of Esp1. However, a deletion of vps64Δ did not have an adaptation defect, nor did it suppress the vps51Δ adaptation defect. (Fig. S5) .
Induction of Increased Autophagy Causes an Adaptation Defect in
Wild-Type Cells. Increased autophagy, in response to nutrient deprivation or after alkylation-mediated DNA damage, can be triggered by inactivating the TOR complex with rapamycin (20, 38) . We asked whether the normal adaptation response of wild-type cells could be blocked by inhibiting TORC1 with rapamycin (Materials and Methods). Because rapamycin-inhibited
WT pep4
Pds1-GFP Fig. 4 . Prevention of vacuolar degradation by pep4Δ reveals that Pds1-GFP can be targeted to vacuole/endosomes. The cells were arrested in G2/M phase for 6 h after galactose induction of HO endonuclease. Pds1-GFP signal intensity was pseudocolored to reflect their signal intensity. These samples were prepared, taken at the same time in the same condition, and the images were equally processed. Arrows point to the position of vacuoles. Adding the nuclear localization signal (NLS) from SV40 to the C terminus of Esp1 suppresses the adaptation defect of vps51Δ and partially of srs2Δ but has no effect on two other adaptation-defective mutations.
cells complete mitosis but fail to complete cytokinesis (39), we could not use our standard adaptation assay. Instead we monitored the proportion of cells suffering a single DSB that arrested with a single nucleus (thus adaptation defective) or could complete mitosis and become binucleate. As shown in Fig. S6 , rapamycin provoked a failure of adaptation. When this assay was repeated in an atg5Δ strain, we found that nuclear division could proceed, supporting the idea that hyperactivation of autophagy by rapamycin results in permanent G2/M arrest following induction of a single unrepaired DSB (Fig. S6) . Because rapamycin has a number of pleiotropic effects (39), we searched for another method to specifically induce autophagy following DNA damage. We took advantage of the discovery that overexpression of a nonphosphorylatable form of ATG13 (ATG13-8SA) induces autophagy without affecting normal cell cycle progression (40) . Here, too, we found that WT cells suffering a DSB were unable to adapt when ATG13-8SA was overexpressed; moreover, deleting either ATG1 or PEP4 suppressed the action of ATG13-8SA overexpression and allowed adaptation (Fig. 7A) . This adaptation defect is dependent on a functional DNA damage response as a deletion of the MEC1 checkpoint kinase completely suppressed the effect of ATG13-8SA overexpression, as did a strain lacking the HO endonuclease cut site (Fig. 7A) . Furthermore, we confirmed that the failure to adapt was correlated with an inability to complete nuclear division by assessing the number of mononucleate (hence arrested) cells. As seen in Fig. S7 , ∼80% of ATG13-8SA overexpressing cells remain arrested with a single nucleus at 24 h.
We then examined the localization of both Pds1-GFP and Esp1-GFP following DNA damage while overexpressing ATG13-8SA. In these cells both Pds1-GFP and Esp1-GFP are unable to localize properly following DNA damage, mirroring what we observe in the GARP mutants ( Fig. 8 and Fig. S8 ). Finally, we found that atg11Δ was also able to suppress the effect of ATG13-8SA overexpression whereas atg17Δ did not (Fig. 7A) .
These results mimic what was seen in the GARP mutations and suggest that increasing autophagy in wild-type cells is sufficient to block adaptation via the CVT pathway.
Rad53 Checkpoint Kinase Is Dephosphorylated in GARP Mutants After DNA Damage. We had previously shown that during the process of adaptation the checkpoint kinase RAD53 is robustly phosphorylated in response to DNA damage and subsequently is dephosphorylated at the time of adaptation. In some adaptation-defective mutants, such as rdh54Δ, ptc2Δ, ptc3Δ, or cdc5-ad, Rad53 remains hyperphosphorylated for at least 24 h (7). In contrast to other adaptation-defective mutations, vps51Δ cells also dephosphorylated Rad53 with kinetics similar to those of WT cells (Fig. 7B) , suggesting that hyperphosphorylation of Rad53 is not responsible for the permanent arrest defect of GARP mutants. Moreover, Rad53 is dephosphorylated after 12 h in ATG13-8SA overexpressed cells (Fig. 7B) , suggesting that these cells closely mimic the enhanced autophagy conditions seen in vps51Δ cells. These results suggest that, whereas the DNA damage response is required to establish cell cycle arrest and designate Pds1's degradation by the CVT pathway, when autophagy is hyperactivated, (A) Induction of autophagy prevents adaptation in WT cells. Adaptation assay was performed as described in Materials and Methods except that strains harboring plasmids were grown in selective media containing raffinose overnight to maintain the plasmid and then unbudded cells were spread onto YEP-Galactose plates and monitored for adaptation at 24 h. ** denotes a statistically significant difference compared with the WT strain overexpressing ATG13-8SA. Error bars reflect SEM of three independent experiments. (B) The Rad53 checkpoint kinase is dephosphorylated in GARP mutants with WT kinetics. The indicated strains were grown in YEP-Lactate and DNA damage was induced by adding galactose to the cultures. Samples were taken at various time points denoted and Western blot was performed as described in Materials and Methods.
this sequence of events makes it impossible for Esp1 to accumulate in the nucleus and execute the release of anaphase.
Recovery Defects of vps51Δ Involve Prb1-Mediated Degradation and
Autophagy. Recovery is defined as the process by which cells turn off the DNA damage checkpoint and resume the cell cycle after repairing the DNA DSB. To assess recovery we used strain YMV80, which repairs a HO-induced DSB through single-strand annealing, in which the flanking homologous sequences are separated by 25 kb and repair requires 6 h (12). To assay recovery, strains in the YMV80 background were grown in preinduction media (YEP-Raffinose or YEP-Lactate) and the cells were then plated on YEPD and YEP-Gal. For each strain viability was measured as a ratio of the number of colonies on YEP-Gal to those on YEPD, as well as the percentage of cells arrested as dumbbells at 24 h. Among previously studied adaptation-defective mutants only srs2Δ, ptc2Δ ptc3Δ, and sae2Δ are recovery defective (12) . Approximately 35% of vps51Δ cells fail to resume cell cycle progression (Fig. 9) . We also found that overexpression of ATG13-8SA, which prevented adaptation in WT cells, also prevents recovery as measured by colony formation on galactose plates (Fig. 9) . As in adaptation assays, we found that atg11Δ and atg1Δ suppressed the recovery defect of overexpressing ATG13-8SA (Fig. 9B ).
Discussion
After DNA damage provokes G2/M arrest, there is a transient activation of the CVT-mediated degradation of Pds1 and the failure of Esp1 to enter the nucleus to allow resumption of mitosis. This process is exacerbated when the CVT pathway of autophagy is hyperactivated, in GARP mutants, by overexpression of ATG13-8SA or by rapamycin treatment; under these conditions cells cannot adapt and show reduced recovery even when damage is repaired. This arrest can be bypassed in at least four ways: (i) by inactivating the DNA damage checkpoint; (ii) by driving Esp1 into the nucleus without its normal chaperone; (iii) by blocking autophagy, specifically with mutations that appear to block CVT pathway; or (iv) by preventing vacuolar proteolysis.
It is striking that deletion of PRB1 or PEP4 can suppress vps51Δ, not only where the vacuole is fragmented, but also when ATG13-8SA is overexpressed and vacuolar morphology is apparently normal. One might have imagined that once cargo such as Pds1 was delivered to the vacuole, it would remain sequestered and could not escape, undegraded, and thus could not enable Esp1 to enter the nucleus and initiate anaphase; but preventing proteolysis does not trap sufficient Pds1 (or some other component) to block mitosis. We suggest that there is some sort of "clogging" of the CVT pathway so that enough Pds1 remains at liberty to carry out its function or that the sequestration of cargo is in some way reversible in the absence of proteolysis. We note that the abundance of Pds1 is increased in a pep4Δ strain, back to wildtype levels (Fig. 3) ; moreover, there is strong localization not only in the vacuole but also in the nucleus (Fig. 4) .
We note that previous studies have suggested that Vps51, apart from its role in endosome-to-Golgi retrograde transport, is essential for Cvt targeting (34), whereas our results suggest that vps51Δ and other GARP mutants actually exacerbate autophagy via this pathway. One possible explanation for this apparent
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Esp1-GFP difference is the effects we see are coupled to the induction of the DNA damage checkpoint, which may alter several cytoplasmic targets in addition to the well-documented effects on septins (19) and dynein-dependent nuclear positioning (41) . Thus, the idea that DNA damage should manifest its response by an alteration of cytoplasmic function is not without precedent. We interpret the defects of GARP mutants in resuming cell cycle progression after DNA damage as a result of an alteration in the localization and stability of a key mitotic activator. Most likely this activator is Esp1 and/or an associated chaperone or cytoplasmic receptor, because we can suppress the adaptation and recovery defects of vesicle transport mutants by driving Esp1 into the nucleus with an SV40 NLS. Previous studies have suggested that the transport of Esp1 into the nucleus is highly regulated, so that even when securin is absent, mitosis is not executed prematurely (32) . After DNA damage there appear to be additional constraints that prevent Esp1 entry or activity. For example, even in a pds1Δ strain, there is a substantial cell cycle delay in response to a single DSB, a delay that is not seen in a strain lacking the ATR homolog, Mec1 (41) . The basis of the inhibition of Esp1 activity is not known; we suggest that separase could be restrained in the cytoplasm by association with a transmembrane-bound receptor, e.g., in the way that the cyclin Cln3 is bound at the endoplasmic reticulum (ER) surface and released by the chaperone Ydj1 (42) . Here the release and/or transport of Esp1 appear to depend on Pds1. Recently, Sarin et al. (31) identified several possible chaperones whose deletions are synthetically lethal with the absence of Pds1. These proteins are candidates to be cochaperones with Pds1 in coordinating the localization of Esp1, but deleting VPS64 did not mimic vps51Δ. Still, there are important questions remaining. For example, is adaptation or recovery accompanied by a change in APC-Cdc20 activity? We do know that APC activity is not required for adaptation as it is reflected in the loss of Rad53 hyperphosphorylation (7, 8) but it should continue to be important for the nuclear degradation of Pds1. It is also intriguing that maintenance of checkpoint-mediated arrest of yeast cells to DNA damage (i.e., a partial loss of telomere protection) depends on APC-Cdh1 (43) .
Defects in GARP mutants have revealed that the DNA damage checkpoint prevents nuclear accumulation of Esp1. Our data suggest that Pds1 is the key factor that is targeted for degradation in the vacuole. It is likely that transporting excess Pds1 to the vacuole is ensuring stable cell cycle arrest in G2 phase and that this transport is likely mediated via the CVT pathway. Consistent with this observation we find that atg1Δ cells, which are defective for both autophagy pathways, show a reduced duration of checkpoint arrest and adapt more extensively. Thus, the sequestration and/or degradation of key mitogenic factors by autophagy could be one way by which cells can maintain a robust checkpoint arrest in response to DNA damage. We note that other factors may also be sequestered or degraded, so that the degradation of Pds1 might not be the only, or even most important, alteration. It is important to note that we also see evidence of vacuolar localization of Pds1-GFP in normal cells after the induction of an unrepaired DSB when vacuolar degradation is blocked by PEP4 deletion. The GARP mutants exacerbate trafficking of Pds1 to the vacuole, but these mutants are exacerbating a normal, underlying phenomenon. We note also that in mammalian cells depleting Rab6, the homolog of Ypt6, results in mitotic defects that suggest a second role for this G protein, much as we suggest here (44) .
Recently there have been other reports of the autophagic degradation of proteins critical for DNA repair. The Sae2 protein is lost from the nucleus and degraded via autophagy in cells suffering DNA damage when treated with an inhibitor of histone deacetylase (25) . Similarly, the Rnr1 protein of the ribonucleotide reductase complex is degraded after alkylation damage; moreover, as we report here, inhibition of the TOR complex exacerbates this response (20) . The degradation of Sae2 upon valproic acid treatment is partially rescued by deletion of ATG19, a gene specifically required for the CVT pathway (25) . However, these experiments did not rule out the possibility that some amount of the degradation could be mediated via the bulk autophagic pathway as well. In this paper, we show that deletion of either ATG1 or ATG11 but not ATG17 suppresses the permanent checkpoint arrest of both vps51Δ and ATG13-8SA overexpressing cells. We suggest, on the basis of our results with the fate of Pds1, that these nuclear proteins are likely targeted for degradation via the CVT pathway.
Another recent report suggests that DNA damage induced by sublethal doses of camptothecin or etoposide results in autophagy-induced cell death in HeLa cells (45) , and treatment of MCF7 breast cancer cell lines with rapamycin appears to inhibit both homologous recombination and nonhomologous end-joining pathways (46) . However, in the latter study it is not clear whether the defect is due to autophagic induction or some other effect of rapamycin treatment. We note that the specific induction of autophagy in strains that robustly activate the DNA damage checkpoint, but that eventually manage to repair the lesion, resulted in a dramatic drop in viability. This could be due to an inability to resume mitosis after DNA damage, defects in homologous recombination, or a combination of both factors. Further work will address the contribution of autophagy in these diverse pathways of homology-driven repair.
As we noted before, the GARP proteins may play roles in several steps in vesicle transport, but are characterized as being defective in Golgi-to-ER retrograde transport because that is the step most clearly affected. However, GARP mutants are just one of many subsets of vesicle transport gene mutations that commonly affect vacuolar protein sorting; but other vps mutations such as those affecting the Retromer complex or the GET complex have no effect in adaptation after DNA damage. We have, however, found deletion mutations in other vesicle transport functions that exhibit similar adaptation defects, including the ARF-GAP Gcs1 and the TRAPP complex protein Gsg1.
Materials and Methods
Yeast Media, GAL-HO Induction, Adaptation, and Recovery Assays. Yeast cells were grown in YEPD [1% yeast extract, 2% peptone, 2% dextrose (wt/vol)] media for normal growth and before spot assays. YEP plus 3% lactic acid (YEP-Lactate) or YEP plus 2% raffinose (YEP-Raffinose) was used as a preinduction medium for most adaptation and recovery assays. Strains carrying plasmids were either pregrown in synthetic media with raffinose or grown in synthetic media with dextrose and then inoculated into YEP-Lactate for preinduction growth of 12-16 h. We have not observed any difference resulting from these preinduction regimes. For adaptation assays unbudded G1 cells in the JKM179 background were micromanipulated into grids on plates of synthetic complete media with 2% galactose supplemented with 1% yeast extract (CYG) or on YEP-Galactose (YEP-Gal) plates and cell cycle progression was monitored at 8, 24, and 48 h (6). The percentage of cells with three or more cells or buds is plotted as a measurement of adaptation. To assay recovery, YMV80 cells (12) were grown overnight in YEP-Lactate and equal numbers of cells were spread onto YEPD (HO off) and YEP-Gal plates (HO on). The percentage of recovery is the ratio of the number of viable colonies (YEP-Gal/YEPD) after 3 d growth at 30°C. To assess a delay in recovery we induced HO expression by adding galactose to YEP-Lactate liquid for 6 h and then plated the cells on YEP-Gal plates. Plates were incubated overnight at 30°C and the number of cells in individual microcolonies was determined 24 h after the initial HO induction.
Strains, Plasmids, and PCR Manipulations. All yeast strains are described in Table S1 . Strain JKM179 and its MATa derivative, JKM139, used for adaptation assays, and strain YMV80, used for recovery assays, have been described in refs. 6 and 12. All other strains were created by transformation of either PCR-generated or plasmid-derived deletion fragments or by standard genetic crosses. Standard PCR conditions and Taq polymerase were used in all cases. Oligo sequences are available on request. The double-deletion strains were created by crossing the appropriate single mutants and dissecting tetrads after sporulating the diploid. We also used rdh54Δ::URA3 (YSL301), srs2Δ::LEU2 (YSL302), and ptc2Δ::URA3 ptc3Δ::KAN (MCM298). Strains without an HO cut site were created by picking rare colonies that grew on galactose plates. Such colonies have cut and then religated MAT by imprecise end joining, generating a sequence that is no longer recognized by the HO endonuclease. The JKM179 strain expressing Esp1-NLS SV40 , under the endogenous Esp1 promoter, was created by transforming with the URA3-marked plasmid pFD026 after cutting with BstAPI.
pFD026 was constructed by amplifying 1.5 kb of 3′ Esp1 ORF, using Esp1 forward and Esp1 reverse primers (NLS sequence included in the primers), and inserting it into pRS306 using BamHI and EcoRI. Single-copy Esp1 NLS SV40 can be introduced into yeast by transforming after cutting pFD026 with BstAPI.
PDS1-GFP and ESP1-GFP strains were constructed using a single-step PCR method (47) . A 6-aa flexible linker (Gly-Gly-Ser-Gly-Gly-Ser) was inserted between the ORFs and GFP to secure functionality of the fusion proteins.
Screen for Novel Recovery Mutants. To identify novel checkpoint recovery mutants, the wild-type recovery strain YMV80 (12) was mutagenized with the mTn-LacZ-LEU2 library (48) , and colonies were assayed for recovery in a replica-plating regime. A total of 17,500 independent colonies were analyzed, and the two strongest secondary positive mutants were analyzed further. One mutant with delayed colony formation (T11) was found to have the transposon inserted at nucleotide 132 of the 495-nt VPS51 ORF. The second mutant (T20) was found to have an insertion at nucleotide 1,435 of the 2,880-nt MSH1 ORF. Cells lacking MSH1 grow poorly on plates containing ethanol and glycerol as the carbon source, which is the second step in our screening regime; hence the apparent recovery defect in this strain is most likely a false positive. This screen was not extended to identify all possible candidates. All image manipulations and fluorescence intensity measurements were carried out using SlideBook software and figures were prepared with Photoshop software.
Western Blots. Western blotting of Rad53 was performed as described in ref. 7 with anti-RAD53 antibodies (provided by M. Foaini). Briefly, indicated strains were grown in YEP-Lacate, galactose was added to induce the DSBs, and they were collected at various time points indicated. Cells were collected by centrifugation and washed with 20% TCA. All purification steps were performed on ice with prechilled solutions. Cell pellets were resuspended in 500 μL 20% TCA and subjected to glass bead lysis. The suspension was collected, 1 mL of 5% TCA was added to wash the beads, and wash minus the glass beads was added to the suspension. The precipitated proteins were collected by centrifugation. Pellets were washed with 1 mL 100% ethanol and proteins solubilized in 200 μL 1 M Tris (pH8.0)/300 μL 3× SDS/PAGE loading buffer [60 mM Tris (pH 6.8), 2% SDS, 10% glycerol, 100 mM DTT, 0.2% bromophenol blue]. After 20 min at 95°C, insoluble material was removed by centrifugation and the supernatant analyzed further (7) . Western blotting of Pds1-GFP and Esp1-GFP was performed as described in ref. 49 , using mouse monoclonal anti-GFP (Roche). . Resumption of growth after nocodazole arrest is not affected by vps51Δ. Cells grown in log phase in YEPD liquid medium were arrested for 12 h with 30 μg/mL nocodazole, such that >95% were arrested as large dumbbells. Plating of individual cells on YEPD plates without nocodazole showed that vps51Δ did not prevent cells from resuming budding and growth.
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